Please login to the form below

5 ways we’re enhancing our services to support our clients in 2023

Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023.

At Fishawack Health (FH), we are constantly looking to progress our organization’s services, processes, and platforms to improve our interdisciplinary offering for clients.

In 2023, we are continuing to expand our offering to meet our clients’ evolving needs in fast-paced and shifting market landscapes. Here, Jon Koch, CEO, outlines the initiatives we look forward to advancing in support of clients innovating in healthcare, from leveraging digital technology to drive valuable connections with patients and healthcare professionals to enhancing our real-world evidence offering and leveraging our proprietary applications to uncover true product value.

What innovative solutions is FH developing to connect our clients with clinicians across the globe?

Jon Koch: We’re continuing to expand partnerships with leading networks of global clinicians in dermatology, hepatology, oncology, and hematology to deliver actionable insights that meet the needs of our clients in fast-moving, complex, and data-rich areas.

Read the full article here

31st January 2023

Share

Tags

Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

Address:
No. 3 Booths Park
Booths Hall
Chelford Road
Knutsford
Cheshire
WA16 8GS
United Kingdom

Latest content on this profile

The challenges of reimbursement and innovative pricing for cell and gene therapies
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of innovative pricing models, including ensuring the model chosen meets the payer’s needs.
Fishawack Health
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes
Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech giants dominate?
Fishawack Health
Fishawack Health welcomes Mario Muredda as its new President of Marketing
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.
Fishawack Health
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023.
Fishawack Health
Why it’s time to apply a payer lens to your early pipeline planning
Value, evidence, and market access experts Jan McKendrick and Andrea Hamlin reveal why applying a payer lens early in the value assessment of pipeline assets is essential for driving commercial success.
Fishawack Health
The fast-paced future of cell and gene therapies
In this report, we interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape for the development of cell and gene therapies and share commercial recommendations from our specialist teams.
Fishawack Health